Endo Completes Acquisition of Par Pharmaceutical and Provides Financial Guidance. DUBLIN , Sept. 28, 2015 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced it has completed its previously announced $8.05 billion acquisition of Par Pharmaceutical Holdings, Inc.
Who bought Par Pharmaceuticals?
Endo International
Ireland-based Endo International has completed the $8.05bn acquisition of US-based Par Pharmaceutical Holdings from private investment firm TPG Capital North America.
Does Endo own par?
In 2015, Endo acquired the specialty generics and sterile injectables company Par Pharmaceutical for $8.05 billion.
What happened to Par Pharmaceuticals?
Endo International (ENDP) said Monday it has agreed to pay $8.05 billion to private equity firm TPG to buy Par Pharmaceutical Holdings, a deal to expand its growing generics business.
Where is Par Pharmaceuticals manufactured?
Rochester, Michigan
With a sterile manufacturing facility located in Rochester, Michigan, Par Sterile Products possesses an unparalleled reputation for high-quality products and an impeccable record of regulatory compliance.
Who owns Endo Pharmaceuticals?
Endo markets its products to primary care physicians and specialists, as well as to other healthcare professionals and retail pharmacies. The company is 60 percent owned by investment firm Kelso & Company.
Is Endo Pharmaceuticals public company?
Endo Pharmaceuticals acquired Algos Pharmaceutical Corporation through a merger. As a result of this merger, Endo Pharmaceuticals became a publicly traded company, under the NASDAQ symbol ENDP.
Where is para Pharma located?
With a sterile manufacturing facility located in Rochester, Michigan, Par Sterile Products possesses an unparalleled reputation for high-quality products and an impeccable record of regulatory compliance.
Who bought out qualitest?
Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
| Reconciliation of Projected GAAP Diluted Earnings Per Share to Adjusted Diluted Earnings Per Share Guidance | ||
|---|---|---|
| Costs related to the acquisition of Qualitest Pharmaceuticals | $0.02 | $0.02 |
Where is Endo International located?
Malvern, Pennsylvania
Endo has global headquarters in Dublin, Ireland and its U.S. corporate office in Malvern, Pennsylvania.
Is Par Pharmaceuticals a public company?
Par capitalized on the trend, going public in 1983. After going public, Par enjoyed several years of strong growth. In 1985 it paid nearly $1.2 million in cash to acquire an 80 percent stake in another publicly traded generic firm, bankrupt BetaMED Pharmaceuticals, Inc.
Where are Par Pharmaceuticals manufactured?
Does Endo own Par Pharmaceuticals?
In 2015, Endo acquired the specialty generics and sterile injectables company Par Pharmaceutical for $8.05 billion. In 2018, Endo settled over 1,200 lawsuits related to its testosterone replacement therapy, Testim, and its undisclosed side effects.
Is Endo International plc a US company?
Endo International plc is an Irish–tax registered generics and specialty branded pharmaceutical company that generated over 93% of 2017 sales from the U.S. healthcare system. While Endo’s management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland…
Is endendo a British company?
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system.
When did Endo buy Paladin Labs Inc?
The company entered the male hypogonadism market later in 2010 with Fortesta 2% gel. In November 2013, Endo agreed to purchase Paladin Labs Inc for about $1.6 billion to gain access to the Canadian market as well as expand into emerging markets.
